---
**Patient:** Christoper Ritchie  
**MRN:** 00293847  
**DOB:** 10/08/1973 (Age 50)  
**Sex:** Male  
**Attending:** Dr. S. Patel  
**Admit Date:** 2024-04-21  
**Location:** MICU, Bed 17  
**Allergies:** NKDA  
**Code Status:** Full  
**Height:** 174 cm  
**Weight:** 98.1 kg  
**BMI:** 32.3 kg/m²  

---

### **History of Present Illness (HPI):**

50-year-old male with PMH of obesity, hyperlipidemia, and recurrent upper respiratory infections, presented to ED 4/21/24 with 2 days of progressive dyspnea, orthopnea, and chest tightness. He reported preceding viral URI symptoms (nasal congestion, sore throat) 1 week prior, treated with Penicillin-V for strep pharyngitis. Symptoms acutely worsened with PND and mild leg swelling. On arrival: BP 84/56, HR 118, SpO2 93% RA, RR 24, T 37.1°C. CXR: pulmonary vascular congestion, mild bibasilar effusions. Troponin mildly elevated, BNP 1932. Echo: LVEF 18%, global hypokinesis, no valvular vegetations. He rapidly developed hypotension refractory to fluids and required norepinephrine. Due to persistent cardiogenic shock, a left-sided Impella CP was placed at bedside for circulatory support.

---

### **Hospital Course:**

- **Day 1 (MICU):** Impella CP inserted via femoral approach. Started on norepinephrine and low-dose dobutamine. Intubated for hypoxic respiratory failure. Broad-spectrum abx given x1 for possible sepsis (later d/c’d, blood cx neg).
- **Day 2-3:** Remained on Impella support, weaned off dobutamine. Extubated successfully on Day 3. Echo: LVEF improved to 28%. Started low-dose carvedilol, IV Lasix. Required intermittent BiPAP overnight.
- **Day 4:** Impella weaned and removed. Vasopressors off. Persistent mild AKI, Cr peaked at 2.1, downtrending. Volume status improved with diuresis. Cardiac MRI: no significant delayed enhancement, suggestive of post-viral myocarditis.
- **Day 5-7:** Progressive improvement. Mobilized to chair. Cr down to 1.3. Transitioned to oral HF regimen (carvedilol, lisinopril, spironolactone, furosemide). Discharged to floor on Day 8, plan outpatient cardiology f/u.

---

### **Problem-Based Assessment & Plan**

---

#### 1. **Acute Decompensated Heart Failure/Cardiogenic Shock**
   - **Assessment:** New severe LV systolic dysfunction, likely post-viral myocarditis. Cardiogenic shock requiring temporary mechanical support (Impella CP).
   - **Plan:**
     - Continue guideline-directed medical therapy for HFrEF (carvedilol, lisinopril, spironolactone, furosemide).
     - Monitor for arrhythmias, daily weights, strict I/O.
     - Cardiology f/u for possible device therapy if no recovery.
     - Outpatient cardiac rehab referral.

#### 2. **Obesity (BMI 32)**
   - **Assessment:** Obesity, risk factor for HF and OSA.
   - **Plan:**
     - Nutrition consult.
     - Encourage gradual weight loss.
     - Consider sleep study outpatient.

#### 3. **Acute Kidney Injury (Multifactorial: hypoperfusion, diuretics)**
   - **Assessment:** AKI on admission, improved with volume management.
   - **Plan:**
     - Monitor renal function.
     - Avoid nephrotoxins.
     - Adjust diuretic dosing as needed.

#### 4. **Recent Streptococcal Pharyngitis/Viral Sinusitis**
   - **Assessment:** Treated with Penicillin-V. No evidence of ongoing infection.
   - **Plan:**
     - No further antibiotics.
     - Monitor for recurrence.

#### 5. **Hyperlipidemia**
   - **Assessment:** LDL 91, non-HDL cholesterol elevated.
   - **Plan:**
     - Resume atorvastatin 40 mg daily.
     - Diet/lifestyle counseling.

#### 6. **ICU-related Issues**
   - **Assessment:** Delirium risk, deconditioning.
   - **Plan:**
     - Early PT/OT.
     - DVT prophylaxis (enoxaparin).
     - Bowel regimen.
     - Sleep hygiene.

---

### **Hospital Medications**

- Furosemide 40 mg IV BID → PO 40 mg BID
- Carvedilol 3.125 mg BID, titrate as tolerated
- Lisinopril 2.5 mg daily
- Spironolactone 25 mg daily
- Atorvastatin 40 mg daily
- Enoxaparin 40 mg SC daily
- PRN acetaminophen, PRN oxycodone for pain
- Sennosides 8.6 mg BID PRN

---

### **Laboratory Results**

| Date       | WBC (K/uL) | Hgb (g/dL) | Plt (K/uL) | Na (mmol/L) | K (mmol/L) | Cl (mmol/L) | CO2 (mmol/L) | BUN (mg/dL) | Cr (mg/dL) | Glu (mg/dL) | Troponin (ng/mL) | BNP (pg/mL) |
|------------|------------|------------|------------|-------------|------------|-------------|--------------|-------------|------------|-------------|------------------|-------------|
| 4/21/24    | 8.5        | 16.0       | 318        | 134         | 4.6        | 101         | 21           | 32          | 1.8        | 112         | 0.11             | 1932        |
| 4/22/24    | 11.2       | 14.4       | 271        | 131         | 5.1        | 99          | 17           | 48          | 2.1        | 146         | 0.09             | 1701        |
| 4/23/24    | 9.6        | 13.1       | 239        | 137         | 4.2        | 104         | 19           | 39          | 1.9        | 121         | 0.06             | 1548        |
| 4/24/24    | 7.8        | 13.8       | 221        | 139         | 4.4        | 106         | 22           | 26          | 1.5        | 98          | 0.04             | *           |
| 4/25/24    | 6.9        | *          | 201        | *           | 4.1        | 109         | 23           | 19          | 1.3        | 102         | <0.01            | 1202        |
| 4/26/24    | 7.3        | 14.2       | 207        | 141         | *          | 103         | 25           | 14          | 1.3        | 105         | *                | 1087        |

*missing value

---

### **Imaging/Procedures**

- **CXR (4/21):** Pulmonary edema, mild bilateral effusions.
- **Echo (4/21):** LVEF 18%, moderate global hypokinesis, mild MR.
- **Echo (4/23):** LVEF 28%, mild MR.
- **Cardiac MRI (4/24):** No delayed enhancement, suggestive of myocarditis.
- **Impella CP Placement (4/21):** Left femoral approach, successful placement, no immediate complications.

---

### **Vital Signs (Select)**
- **BP:** 84/56 → 102/66 (after support)
- **HR:** 118 → 88
- **RR:** 24 → 16
- **SpO2:** 93% RA → 98% 2L NC
- **Temp:** 37.1°C → 36.8°C

---

### **Discharge Planning**

- Anticipated discharge: 4/29/24 to home with close cardiology f/u
- Home HF regimen, weight monitoring
- Outpatient labs 1 week post-discharge
- Education: heart failure, fluid restriction, daily weights

---

**Attending:** S. Patel, MD  
**Resident:** J. Thomas, MD  
**Date/Time:** 4/27/2024 07:34

---
